A Long-term Follow-up Study for HIV-infected Individuals Who Have Participated in HIV-NAT Study Protocols

What this Trial Is About

Researchers are conducting a long-term observational study to understand the outcomes of people living with HIV who have participated in previous HIV-NAT trials. This study aims to provide insights into the long-term safety and durability of different antiretroviral treatments, the effectiveness of HIV viral load and CD4 cell counts in predicting disease progression and mortality, and the impact of adherence to treatment. It also seeks to explore various complications and quality of life over an extended period. The study follows participants who were previously or are currently involved in HIV-NAT trials, collecting and evaluating ongoing clinical outcomes. It assesses long-term consequences related to different antiretroviral drug classes, including risks of metabolic issues like lipodystrophy, resistance patterns, and effects on various body systems such as cardiovascular, renal, and hepatic functions. The study also monitors opportunistic infections or malignancies among co-infected patients and evaluates immune recovery and quality of life. Participants provide written consent and their health is monitored over a period that can extend up to 30 years. The study involves regular evaluations of clinical outcomes, adherence to medication, and quality of life assessments. Researchers analyze data to better understand long-term effects and disease progression in HIV, helping to inform future treatment approaches and patient care strategies.

A Long-term Follow-up of the HIV-NAT Cohort